Physician Wealth Advisors’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$481 Buy
+130
New +$488 ﹤0.01% 2276
2026
Q2
– Sell
-283
Closed -$2.17K – 2382
2026
Q1
$2.17K Hold
283
– – ﹤0.01% 1323
2025
Q4
$3.2K Hold
283
– – ﹤0.01% 1109
2025
Q3
$2.6K Hold
283
– – ﹤0.01% 1108
2025
Q2
$1.95K Buy
+283
New +$1.51K ﹤0.01% 1055

Other funds holding FULC

Physician Wealth Advisors's FULC Position: Q3 2026 in Review

Physician Wealth Advisors opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 130 shares worth $481. The stake represents ﹤0.01% of the portfolio and ranks #2276 among its holdings. This is a return to the name: Physician Wealth Advisors previously reported a position in FULC as recently as Q1 2026.

Physician Wealth Advisors first reported a position in FULC in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.2K in Q4 2025. 151 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • Physician Wealth Advisors held 130 shares of Fulcrum Therapeutics worth $481 as of Q3 2026.
  • Fulcrum Therapeutics was a new Physician Wealth Advisors position in Q3 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2276 holding.
  • Physician Wealth Advisors first reported a position in Fulcrum Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Physician Wealth Advisors's Fulcrum Therapeutics position peaked at $3.2K in Q4 2025.
  • 151 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.